UCSF

ZINC02568036

Substance Information

In ZINC since Heavy atoms Benign functionality
October 27th, 2004 23 No

Other Names:

1-(((5-(4-Nitrophenyl)-2-furanyl)methylene)amino)-2,4-imidazolidinedione

1-((5-(4-Nitrophenyl)furfurylidene)amino)imidazolidine-2,4-dione, sodium salt; 1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin sodium; 2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-, sodium salt; 2C14H9N4O5.2Na; DANTRIUM; DA

1-((5-(p-Nitrophenyl)furfurylidene)amino)hydantoin

1-((5-(p-nitrophenyl)furfurylidene)amino)hydantoin anion; dantrolene anion

1-((5-(p-nitrophenyl)furfurylidene)amino)hydantoin; Dantrolene

1-({(1E)-[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)imidazolidine-2,4-dione

1-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)imidazolidine-2,4-dione

1-[(5_(p-Nitro_phenyl)furfurylidene)amino]hydantoin sodium salt

1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione

14663-23-1; C07933; Dantrolene sodium anhydrous

2,4-Imidazolidinedione, 1-(((5-(4-nitrophenyl)-2-furanyl)methylene)amino)-

2,4-Imidazolidinedione, 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-

7261-97-4

7261-97-4; D02347; Dantrolene (USAN/INN)

AC1OC9NE

BCBcMAP01_000067

BIDD:GT0187

BPBio1_000246

BRD-K81272440-001-02-6

BRD-K81272440-236-05-1

BRN 0705189

BSPBio_000222

BSPBio_001305

BSPBio_003074

C06939

C14H10N4O5

CHEBI:4317

CHEMBL1201288

CID6914273

CPD000326766; Dantrolene sodium salt; SAM002703135

CPD000326766; Dantrolene Sodium; SAM002703135

D02347

Dantrium

Dantrium Intravenous

Dantrolene

Dantrolene (BAN

Dantrolene (USAN/INN)

Dantrolene free base

Dantrolene free base; (for R&D only)

Dantrolene Sodium

Dantrolene sodium hemiheptahydrate

Dantrolene sodium salt

Dantrolene sodium salt dihydrate; Prestwick_825

Dantrolene Sodium Salt Hydrate

DANTROLENE SODIUM; dantrolene sodium

Dantrolene [USAN:BAN:INN]

dantrolene(1-)

Dantrolene, Sodium Salt

dantrolene; dantroleno; dantrolenum

Dantrolenesodium

Dantrolenesodiumsalt

Dantroleno

Dantroleno [INN-Spanish]

Dantroleno [INN-Spanish];Dantrolenum [INN-Latin]

Dantrolenum

Dantrolenum [INN-Latin]

DAP000499

DB01219

EINECS 230-684-8

F-368

F-368; F-440

F-440

FDA

FDA)

HMS1361B07

HMS1791B07

HMS1989B07

HSDB 3050

Hydantoin, 1-((5-(p-nitrophenyl)furfurylidene)amino)-

IDI1_000898

IDI1_033775

INN

JAN

LS-119597

LS-127883

LS-132754

LS-187306

LS-65139

LS-76264

LS-79782

MFCD00079130

MFCD00867709

MFCD06198666

MFCD07357270

MFCD20257229

MolPort-006-389-324

NCGC00163132-01

NCGC00163402-01

NCGC00163402-02

nchembio.368-comp3

Prestwick2_000291

Prestwick3_000291

Ryanodex

sodium 1-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate pentahydrate

Spectrum5_001752

UNII-F64QU97QCR

USAN

USAN)

USAN); Dantrolene Sodium (BAN

ZINC26894874

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 1.75 4.42 -23.48 1 9 0 121 314.257 4
Mid Mid (pH 6-8) 1.93 1.83 -52.95 0 9 -1 127 313.249 4

Vendor Notes

Note Type Comments Provided By
PUBCHEM_SUBSTANCE_COMMENT 14663-23-3 PDSP via PubChem
ALOGPS_SOLUBILITY 8.05e-02 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Therapy muscle relaxant (skeletal) SMDC MicroSource
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : MZ-3030; NCC_SUPPLIER_SAMPLE_COMMENTS : ORANGE POWDER; 1 Sodium NIH Clinical Collection via PubChem
UniProt Database Links RYR1_HUMAN ChEBI
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: MZ-3030; SALT: 1 Sodium; SUPPLIER_COMMENTS: ORANGE POWDER NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
Q28953-1-E Ryanodine Receptor 2 (cluster #1 Of 1), Eukaryotic Eukaryotes 300 0.40 Binding ≤ 10μM
RYR1-1-E Ryanodine Receptor 1 (cluster #1 Of 1), Eukaryotic Eukaryotes 300 0.40 Binding ≤ 10μM
RYR3-1-E Ryanodine Receptor 3 (cluster #1 Of 1), Eukaryotic Eukaryotes 300 0.40 Binding ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 6310 0.32 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
RYR1_PIG P16960 Ryanodine Receptor 1, Pig 210 0.41 Binding ≤ 1μM
Q28953_PIG Q28953 Ryanodine Receptor 2, Pig 210 0.41 Binding ≤ 1μM
RYR3_HUMAN Q15413 Ryanodine Receptor 3, Human 210 0.41 Binding ≤ 1μM
RYR1_PIG P16960 Ryanodine Receptor 1, Pig 1500 0.35 Binding ≤ 10μM
Q28953_PIG Q28953 Ryanodine Receptor 2, Pig 1500 0.35 Binding ≤ 10μM
RYR3_HUMAN Q15413 Ryanodine Receptor 3, Human 1500 0.35 Binding ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 10000 0.30 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Stimuli-sensing channels

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.